Titan Biotech Ltd. - Research Center
524717 TITANBIO Group (X) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
78.17 |
76.83 |
61.06 |
62.49 |
62.08 |
Operating profit |
16.60 |
18.55 |
13.38 |
17.80 |
26.48 |
Interest |
0.57 |
0.35 |
0.35 |
0.43 |
0.62 |
Gross profit |
16.87 |
19.37 |
13.60 |
17.74 |
26.18 |
EPS (Rs) |
13.84 |
16.55 |
11.17 |
15.07 |
22.97 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
0.83 |
1.17 |
0.57 |
0.37 |
0.32 |
Stock adjustment |
-3.58 |
-1.06 |
-0.85 |
0.68 |
-2.60 |
Raw material |
39.36 |
39.63 |
29.46 |
29.67 |
25.90 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
10.88 |
8.32 |
7.71 |
6.62 |
5.31 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
14.90 |
11.39 |
11.37 |
7.72 |
6.98 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
1.66 |
1.24 |
1.26 |
1.10 |
0.89 |
Taxation |
3.78 |
4.45 |
3.10 |
4.18 |
6.40 |
Net profit / loss |
11.44 |
13.68 |
9.23 |
12.45 |
18.98 |
Extra ordinary item |
- |
- |
- |
- |
0.09 |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
8.26 |
8.26 |
8.26 |
8.26 |
8.26 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
21.24 |
24.14 |
21.91 |
28.49 |
42.65 |
GPM (%) |
21.35 |
24.84 |
22.06 |
28.23 |
41.96 |
NPM (%) |
14.48 |
17.54 |
14.98 |
19.81 |
30.42 |